Alternatives to GBCA: Are We There Yet?

Jeffrey R Wesolowski, Andrew Kaiser

Journal: Topics in magnetic resonance imaging : TMRI 2017;25(4):171-5

PMID: 27367312

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Gadolinium has been widely used as the contrast agent of choice for magnetic resonance imaging (MRI). However, gadolinium administration is not always desired due to its inherent enhancement properties and potential side effects (nephrogenic systemic fibrosis). This article reviews gadolinium alternatives, iron-, and manganese- based agents, and their current clinical usage for contrast-enhanced MRI examinations.

Address: University of Michigan Health System, Ann Arbor, MI.

DOI: 10.1097/RMR.0000000000000096